Chemical Structure (Lorbrena 01)
Lorbrena Tablet, Film Coated
Product Images NDC 0069-0231
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lorbrena (NDC 0069-0231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lorbrena 02)
This is a comparison of two drugs, Lorbrena (N=149) and Crizotinib (N=147), in the treatment of cancer. The median survival time for patients taking Lorbrena has not been reached, whereas for those taking Crizotinib it was 9.3 months. The hazard ratio of Lorbrena versus Crizotinib was 0.28, with a 95% confidence interval of 0.19 to 0.41, and a p-value of less than 0.0001. The graph shows the survival curves for the two drugs over time.*
Logo (Lorbrena 03)
This is a description for a medicine, which is being distributed by Pfizer Labs. Pfizer Labs is a division of Pfizer Inc, located in New York City, with a zip code of 10017.*
Logo (Lorbrena 04)
This text is a description of the distributor of a product, Pfizer Labs, which is a division of Pfizer Inc, located in New York City.*
Principal Display Panel (25 mg Tablet Bottle Label)
This is a prescription drug called Lorbrena (lorlatinib) tablets that comes in a bottle with 30 tablets each containing 25 mg and should be stored at 20°C to 25°C. It should be dispensed in tight, child-resistant containers. The prescribing information should be consulted for dosage and use. The drug is made in Ireland and distributed by Pfizer Labs. The NDC is 0069-0227-01. The other text is not-available or irrelevant.*
Principal Display Panel (100 mg Tablet Bottle Label)
This is a prescription drug called Lorbrena® (lorlatinib) available in tablet form with a strength of 100 mg. It is to be stored at a temperature range of 20°C to 25°C (68°F to 77°F), and can be dispensed in tight, child-resistant containers. For more information on dosage and usage, please refer to the accompanying prescribing information. The drug is distributed by Pfizer Labs, a division of Pfizer Inc, and is made in Ireland. The National Drug Code (NDC) for this drug is 0069-0231-01. The remaining text is either illegible or non-English characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
